Supreme Court Draws a Clear Line on Stem Cell Therapy for Autism: What Every Parent Must Know

In a landmark ruling dated January 30, 2026, the Supreme Court of India delivered a definitive verdict in Yash Charitable Trust v. Union of India, holding that stem cell therapy for Autism Spectrum Disorder (ASD) cannot continue as a commercial endeavour. What the court decided: The Court directed the Secretary of the Ministry of Health and Family Welfare to re-route patients already undergoing therapy to clinical trials within four weeks, and suggested establishing a Pan-Indian Authority for regulating stem cell research. How to Protect Yourself a. Verify Credentials: Ask if the provider holds Central Drugs Standard Control Organisation (CDSCO) or Ethics Committee approval. b. Consult your Development Paediatrician before any non-standard intervention. c. Report suspicious clinics to the National Medical Commission or your State Medical Council. d. Join regulated clinical trials: Participation in approved research is legal and offers you safeguards, including compensation for adverse events. e. Connect with credible Autism Community: Can help you identify evidence-based resources.